In a 30-year-old woman with amenorrhea due to hyperprolactinemia , serum PRL increased to twice the basal amount in response to growth hormone-releasing hormone (GHRH) . Roentogenological studies revealed no pituitary adenoma but empty sella. Bromocriptine therapy normalized serum PRL and made the paradoxical response to GHRH disappear. The paradoxical response did not occur in any of eight other patients with hyperprolactinemia due to prolactinoma. Although this case is rare , GHRH stimulates PRL as well as GH release remarkably in some cases with hyperprolactinemia without a GH-producing tumor.
Abstract.
In a 30-year-old woman with amenorrhea due to hyperprolactinemia , serum PRL increased to twice the basal amount in response to growth hormone-releasing hormone (GHRH) . Roentogenological studies revealed no pituitary adenoma but empty sella. Bromocriptine therapy normalized serum PRL and made the paradoxical response to GHRH disappear. The paradoxical response did not occur in any of eight other patients with hyperprolactinemia due to prolactinoma. Although this case is rare , GHRH stimulates PRL as well as GH release remarkably in some cases with hyperprolactinemia without a GH-producing tumor.
(Endocrinol Japon 38: 183-186, 1991)
IT HAS been well documented that about 50% of patients with acromegaly exhibit a paradoxical PRL response to GHRH [1] . However, PRL response to GHRH in patients with hyperprolactinemia has not yet been well established.
Serri et al. [2] recently reported a statistically significant PRL increase after GHRH load in 13 patients with microprolactinoma.
However, the magnitude of the increase expressed in terms of the area under the curve is only 109% on average, taking the basal level as 100%. Table 2 .
Results
The maximum positive response of serum PRL to GHRH in the 8 patients with hyperprolactinemia due to prolactinoma was less than 120% in terms of the percentage of the basal level (Fig. 2) . The PRL response to GHRH in the presented case ( Fig. 1) was remarkably high compared to those in the other 8 patients with prolactinoma (Fig. 2) . In the 8 patients with prolactinoma, there was no statistically significant correlation between the basal serum PRL level and the PRL response at 15 min or 30 min after the GHRH injection, r= 0.402 or r=0.107. 
Discussion
We reported the first case with hyperprolactinemia and empty sella whose serum PRL increased in response to GHRH to more than twice the basal level. The serum PRL response to GHRH in normal subjects is reported to be either negative or slight if any [1] . There is the possibility that GHRH might be a weak stimulator of PRL release in the physiological condition. However, the magnitude of the increase so far reported is always less than the basal level.
Serri et al. [2] have recently reported a statistically significant PRL increase after GHRH injection compared with saline in 13 patients with microprolactinoma. They also stated that this increase is positively correlated with the basal PRL level.
In contrast to Serri's observation, our 8 patients with prolactinoma showed no significant correlation between the basal PRL level and the PRL response to GHRH. Even in Serri's cases, the correlation recalculated by us after eliminating one case whose basal PRL level is the highest among the 13 cases showed no significant correlation. These two results indicate that PRL usually does not respond to GHRH more dramatically in prolactinoma than in normal subjects. An in vitro study by Ishibashi et al. [4] in which GHRH did not stimulate PRL release from cultured cells of prolactinoma also confirms our results. On the other hand, the serum PRL response to GHRH of the case presented is much greater than that obtained in normal subjects.
The mechanism of the paradoxical response in the present case needs some discussion. In general, paradoxical response of pituitary hormones to hypothalamic releasing hormones has been documented in pituitary adenomas; GH to TRH [5] or LHRH [6, 7] and PRL to GHRH in acromegaly [1] , ACTH to LHRH in Cushing's disease [8] , LH or FSH to TRH in gonadotropin secreting adenoma [9] and in systemic diseases; GH to TRH in chronic liver disease, chronic renal failure, IDDM, pellagrin [ 10] , depression [11] and anorexia nervosa [ 12] . The present case represents no acromegalic features, no pituitary disease listed above or systemic disease. The roentgenological studies revealed only empty sella in this case. The coexistence of microprolactinoma and empty sella is well known [13, 14] . Although serum PRL does not respond to TRH in most patients with prolactinoma, it does respond in 10-20% of them [15] 
